The National Insurance Crime Bureau (NICB) today released a national analysis of vehicle theft which compares annual statistics for thefts, population and vehicle registrations from 1960 through 2013. Just released FBI crime figures for 2013 show that 699,594 vehicles were reported stolen last year–a 58 percent reduction–from 1991 when vehicle theft reached an all-time high of 1,661,738.
Over the years, the single-vehicle family–long the norm in America–became the exception as it gave way to families with multiple vehicles. In 1960, there were 74,159,209 vehicles registered across the nation whose population that year was 180,671,158. Registrations as a percentage of that population stood at 41 percent. In 2012, that figure increased to 80.8 percent as registrations climbed to 253,639,386 distributed within the nation’s 313,873,685 in population.
To view the Multimedia News Release, go http://www.multivu.com/players/English/70506513-national-insurance-crime-bureau-historical-look-at-vehicle-theft-in-united-states/
Samruk Kazyna, Kazakhstan’s sovereign wealth fund managing major strategic state assets with the combined value of close to $100 bn, is overhauling its business strategy, including approaches to investments and to asset management.
New management mechanisms will soon be introduced in all of the Fund’s companies. As early as 2014, business processes reengineering will start in three pilot organizations – diversified transport holding Kazakhstan Temir Zholy, oil and gas company KazMunaiGaz and postal service operator KazPochta.
These measured will result in operating costs reduction of 20% by 2017, and Samruk Kazyna’s economic value added will generate more than $11.2 bn for Kazakhstan’s economy.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762559-samruk-kazyna-transformation-forum/
Today, Novo Nordisk announced new phase 3 interim data from its guardianTM2 trial for its recombinant coagulation factor VIII (rFVIII) product NovoEight® (turoctocog alfa), the first new rFVIII molecule in over a decade, which shows that it provides long-term reduction from bleeding in people with haemophilia A when used as a preventative treatment.1 The results were presented at the World Federation of Haemophilia (WFH) World Congress and support findings from other studies within the guardianTM clinical programme that found NovoEight® demonstrated good efficacy in preventing and treating bleeds without inhibitor development in previously treated patients.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400529-novoeight-reduction-of-bleeding-haemophilia-a
Se pone en marcha el primer estudio integral a largo plazo que compara diferentes medicaciones para el tratamiento de la diabetes tipo 2 a escala nacional. El estudio GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness - Estrategias para la reducción de la glucemia en la diabetes: una comparativa de la eficacia) comparará los efectos beneficiosos y riesgos a largo plazo de cuatro fármacos ampliamente utilizados en el tratamiento de la diabetes, en combinación con metformina, la medicación de primera línea más frecuente para tratar la diabetes tipo 2. El estudio GRADE está buscando voluntarios latinos.
Para ver el Multimedia News Release, vaya a http://www.multivu.com/mnr/65066-nih-grade-study-on-type-2-diabetes-medication-seeks-latino-volunteers
The first comprehensive long-term study comparing different medications for type 2 diabetes is launching nationwide. The GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study will compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64578-grade-glycemia-reduction-approaches-in-diabetes-comparative-effectiveness
As businesses become increasingly frustrated by shelf-life hardware and out-of-the-box software, hosted solutions have grown increasingly popular, with 81% of corporates already using or planning to use cloud-based services according to recent research.
42% of SMEs who subscribed to hosted services did so in the last 12 months, showing the swift emergence of cloud solutions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62395-TalkTalk-business-hosting-solutions
For the millions who suffer from Gastroesophageal Reflux Disease (GERD), a study published today in the New England Journal of Medicine (NEJM) provides clinical evidence of safety and effectiveness for a new, FDA-approved medical device. Torax Medical’s LINX® Reflux Management System was studied in a controlled, prospective, multicenter trial involving 14 U.S. and European medical centers as part of the FDA pre-market approval process. The patients were evaluated before and after treatment to determine the effect of the LINX System on their GERD using pre-defined success criteria, which included reduction of esophageal acid, improvement in quality of life and elimination of reflux medications.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60077-torax-medical-linx-reflux-management-system-clinical-study-published
Clinic Dermatech, a leading skin care center in Delhi, was recently recognized with the title of ‘most promising skincare clinic in Delhi’. This is a great achievement for the company and its employees. Watch Mr. Rajesh Singh, Vice president of Clinic Dermatech talk about the company’s growth, success and future plans. http://www.clinicdermatech.com/
Coca-Cola Enterprises (NYSE/NYSE Euronext Paris: CCE), which produces, markets and distributes Coca-Cola products in Western Europe, is today announcing two new initiatives aimed at improving recycling behavior and infrastructure, as part of its journey to becoming a low-carbon, zero-waste business. CCE’s sustainability plan commits it to setting the standard for sustainable packaging, achieving zero waste in its own operations and recycling more packaging than it uses.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56620-coca-cola-enterprises-sustainability
Takeda today announced the launch of a new expert Report on COPD, introduced at a Takeda organised press conference on the occasion of the 2012 European Respiratory Society (ERS) Annual Congress taking place from 1- 5 September in Vienna, Austria.
The Report, entitled ‘The Shifting Paradigm in Chronic Obstructive Pulmonary Disease (COPD) Management,’ was initiated and developed by Takeda Pharmaceuticals International GmbH and is a compilation of opinion articles from a panel of key international respiratory experts, the European Federation of Allergy and Airways Diseases Patients’ Association (EFA) and COPD patients, reflecting updated guidance and research. The new expert Report was developed in response to a recent shift in emphasis in COPD management which now places future risk at equal importance to treatment of current disability. Treatment objectives are now divided into two groups: reducing symptoms and reducing risk.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56582-expert-report-on-copd-launch
Achieving another wireless connectivity milestone, Texas Instruments Incorporated (TI) (NASDAQ: TXN) today introduced the WiLink™ 8.0 product family: a collection of 45-nanometer single-chip solutions that integrate up to five different radios, and set the stage for next-generation mobile Wi-Fi®, GNSS, NFC, Bluetooth® and FM transmit/receive applications. The WiLink 8.0 architecture supports various combinations of these technologies, allowing for customized solutions to address the unique needs and price points of all mobile markets. Each chip variant comes in a compact WSP package that can be mounted directly on a PCB, and includes all required RF front ends, a complete power management system, and comprehensive coexistence mechanisms. At the system level, the five-radio WiLink 8.0 chip offers a 60 percent cost reduction, 45 percent decrease in size and 30 percent lower power consumption compared to traditional multi-chip offerings. Complete details: www.ti.com/wilink8.
To view Multimedia News Release, go to http://www.multivu.com/mnr/54040-texas-instruments-ti-wilink8-5-in-1-wireless-connectivity-next-gen-mobile
